Payer PolicyActive
Diagnostic Imaging - Medicare Advantage
HUMANA-DIAGNOSTIC-IMAGING-MA
Humana
Effective: December 1, 2025
Updated: December 12, 2025
Policy Summary
This Humana Medicare Advantage diagnostic imaging policy states that imaging services (CT, MRI, MRA, PET, SPECT, etc.) are covered when reasonable and necessary per Medicare and applicable NCDs/LCDs. It provides explicit medical necessity criteria for brain MRI in patients prescribed Leqembi (lecanemab-irmb) — prior to initiation (within 1 year), prior to the 3rd/5th/7th/14th infusions, or for signs/symptoms suggestive of ARIA — and identifies certain HCPCS codes (S8037, S8042) as not covered.
Coverage Criteria Preview
Key requirements from the full policy
"Diagnostic imaging services (CT, CTA, MRI, MRA, CMR, PET, PET/CT, PET/MRI, SPECT) that are reasonable and necessary for the diagnosis and treatment of illness or injury or to improve the functionin..."
Sign up to see full coverage criteria, indications, and limitations.